Health-related quality of life (HRQOL) and patient-centered outcomes with maintenance olaparib compared with placebo following chemotherapy in patients with germline BRCA-mutated platinum-sensitive relapsed serous ovarian cancer: SOLO2 Phase III

被引：0

作者：

Hasenburg, A. ^{[1
]}

Harter, P. ^{[2
]}

Park-Simon, T-W. ^{[3
]}

Gropp-Meier, M. ^{[4
]}

Heitz, F. ^{[2
]}

Soergel, P. ^{[5
]}

Ataseven, B. ^{[6
]}

Friedlaender, M. ^{[7
]}

Hilpert, F. ^{[8
]}

Pujade-Lauraine, E. ^{[9
]}

机构：

[1] Univ Ctr Mainz, Dept Gynecol & Obstet, Klin & Poliklin Geburtshilfe & Frauengesundheit, Mainz, Germany

[2] Kliniken Essen Mitte, Gynakol & Gyn Onkol, Essen, Germany

[3] Hannover Med Sch, Klin Frauenheilkunde & Geburtshilfe, Hannover, Germany

[4] Malteserkrankenhaus Bonn, Ravensburg, Germany

[5] Hannover Med Sch, Hannover, Germany

[6] Kliniken Essen Mitte, Klin Senol, Essen, Germany

[7] Prince Wales Hosp, Randwick, NSW, Australia

[8] Univ Klinikum Schleswig Holstein, Klin Gynakol & Geburtshilfe, Kiel, Germany

[9] Univ Paris 05, Paris, France

来源：

ONCOLOGY RESEARCH AND TREATMENT | 2018年 / 41卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

538

引用

页码：88 / 89

页数：2

共 48 条

[1] Health-related quality of life (HRQOL) and patient-centered outcomes with maintenance olaparib compared with placebo following chemotherapy in patients with germline (g) BRCA-mutated (m) platinum-sensitive relapsed serous ovarian cancer (PSR SOC): SOLO2 phase III trial
Friedlander, Michael
Gebski, Val
Gibbs, Emma
Bloomfield, Ralph
Hilpert, Felix
Wenzel, Lari B.
Joly, Florence
Eek, Daniel
Rodrigues, Manuel
Clamp, Andrew R.
Penson, Richard T.
Provencher, Diane M.
Korach, Jacob
Huzarski, Tomasz
Vidal, Laura
Salutari, Vanda
Scott, Clare L.
Nicoletto, Maria Ornella
Tamura, Kenji
Pujade-Lauraine, Eric
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
[2] HEALTH-RELATED QUALITY OF LIFE (HRQOL) AND PATIENT-CENTRED OUTCOMES WITH OLAPARIB MAINTENANCE POST-CHEMOTHERAPY IN PATIENTS WITH GERMLINE BRCA-MUTATED PLATINUM-SENSITIVE RELAPSED SEROUS OVARIAN CANCER (PSR SOC)
Friedlander, M.
Gebski, V.
Gibbs, E.
Bloomfield, R.
Hilpert, F.
Wenzel, L. B.
Joly, F.
Eek, D.
Rodrigues, M.
Clamp, A.
Penson, R.
Provencher, D.
Korach, J.
Huzarski, T.
Vidal, L.
Salutari, V.
Scott, C.
Nicoletto, M. O.
Tamura, K.
Pujade-Lauraine, E.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 1941 - 1941
[3] Adverse events (AEs) with maintenance olaparib tablets in patients (pts) with BRCA-mutated (BRCAm) platinum-sensitive relapsed serous ovarian cancer (PSR SOC): Phase III SOLO2 trial
Ledermann, Jonathan A.
Lortholary, Alain
Penson, Richard T.
Gibbs, Emma
Provencher, Diane M.
Bruchim, Ilan
Huzarski, Tomas
Barretina-Ginesta, Maria Pilar
Sabbatini, Roberto
Mileshkin, Linda R.
Colombo, Nicoletta
Park-Simon, Tjoung-Won
Matsumoto, Koji
Sonke, Gabe S.
Mikheeva, Olga N.
Kim, Jae-Weon
Girotto, Gustavo Colagiovanni
Denys, Hannelore
Lowe, Elizabeth S.
Pujade-Lauraine, Eric
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
[4] Concordance between CA-125 and RECIST progression in patients with germline BRCA-mutated platinum-sensitive relapsed ovarian cancer treated in the SOLO2 trial with olaparib as maintenance therapy after response to chemotherapy
Tjokrowidjaja, Angelina
Lee, Chee K.
Friedlander, Michael
Gebski, Val
Gladieff, Laurence
Ledermann, Jonathan
Penson, Richard
Oza, Amit
Korach, Jacob
Huzarski, Tomasz
Manso, Luis
Pisano, Carmela
Asher, Rebecca
Lord, Sarah J.
Kim, Se Ik
Lee, Jung-Yun
Colombo, Nicoletta
Park-Simon, Tjoung-Won
Fujiwara, Keiichi
Sonke, Gabe
Vergote, Ignace
Kim, Jae-Weon
Pujade-Lauraine, Eric
EUROPEAN JOURNAL OF CANCER, 2020, 139 : 59 - 67
[5] EFFICACY AND SAFETY OF MAINTENANCE OLAPARIB BY PATIENT AGE IN NON-GERMLINE BRCA-MUTATED PLATINUM-SENSITIVE RELAPSED OVARIAN CANCER IN OPINION
Skof, E.
Bjurberg, M.
Rubio Perez, M. J.
Davidson, D.
Blakeley, C.
Bennett, J.
Poveda, A.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2021, 31 : A202 - A203
[6] OLAPARIB MONOTHERAPY VERSUS (VS) CHEMOTHERAPY FOR GERMLINE BRCA-MUTATED (GBRCAM) PLATINUM-SENSITIVE RELAPSED OVARIAN CANCER (PSR OC) PATIENTS (PTS): PHASE III SOLO3 TRIAL
Penson, R. T.
Valencia, R. V.
Cibula, D.
Colombo, N.
Ill, C. L.
Bidzinski, M.
Kim, J. W.
Nam, J. H.
Madry, R.
Hernandez, C. H.
Mora, P.
Ryu, S. Y.
Milenkova, T.
Lowe, E.
Barker, L.
Scambia, G.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A21 - A21
[7] Health-related quality of life and patient-centred outcomes with olaparib maintenance after chemotherapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT Ov-21): a placebo-controlled, phase 3 randomised trial
Friedlander, Michael
Gebski, Val
Gibbs, Emma
Davies, Lucy
Bloomfield, Ralph
Hilpert, Felix
Wenzel, Lari B.
Eek, Daniel
Rodrigues, Manuel
Clamp, Andrew
Penson, Richard T.
Provencher, Diane
Korach, Jacob
Huzarski, Tomasz
Vidal, Laura
Salutari, Vanda
Scott, Clare
Nicoletto, Maria Ornella
Tamura, Kenji
Espinoza, David
Joly, Florence
Pujade-Lauraine, Eric
LANCET ONCOLOGY, 2018, 19 (08): : 1126 - 1134
[8] Olaparib maintenance monotherapy in Chinese patients with platinum-sensitive relapsed ovarian cancer: China cohort from the phase III SOLO2 trial
Liu, Jihong
Yin, Rutie
Wu, Lingying
Zhu, Jianqing
Lou, Ge
Wu, Xiaohua
Zhou, Qi
Gao, Yunong
Kong, Beihua
Lu, Xin
Wang, Jing
Chen, Youguo
Cheng, Ying
Wang, Yueling
Lu, Weiguo
Li, Wei
Ma, Xin
Hsu, Kate
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2022, 18 (06) : 714 - 722
[9] Olaparib monotherapy versus (vs) chemotherapy for germline BRCA-mutated (gBRCAm) platinum-sensitive relapsed ovarian cancer (PSR OC) patients (pts): Phase III SOLO3 trial.
Penson, Richard T.
Valencia, Ricardo Villalobos
Cibula, David
Colombo, Nicoletta
Leath, Charles A.
Bidzinski, Mariusz
Kim, Jae-Weon
Nam, Joo-Hyun
Madry, Radoslaw
Hernandez, Carlos Hernandez
Mora, Paulo Alexandre Ribeiro
Ryu, Sang Young
Milenkova, Tsveta
Lowe, Elizabeth S.
Barker, Laura
Scambia, Giovanni
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
[10] Olaparib Versus Nonplatinum Chemotherapy in Patients With Platinum-Sensitive Relapsed Ovarian Cancer and a Germline BRCA1/2 Mutation (SOLO3): A Randomized Phase III Trial
Penson, Richard T.
Villalobos Valencia, Ricardo
Cibula, David
Colombo, Nicoletta
Leath, Charles A., III
Bidzinski, Mariusz
Kim, Jae-Weon
Nam, Joo Hyun
Madry, Radoslaw
Hernandez, Carlos
Mora, Paulo A. R.
Ryu, Sang Young
Milenkova, Tsveta
Lowe, Elizabeth S.
Barker, Laura
Scambia, Giovanni
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (11) : 1164 - +

← 1 2 3 4 5 →